Skip to content

Bone Mineral Density Quantitative Trait Locus 12 C2675513

Published: July 22, 2026Updated: August 20, 2026

A genetic marker associated with bone mineral density. It may influence bone strength and osteoporosis risk. Management focuses on bone-healthy lifestyle habits.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Joint pain or stiffness

(musculoskeletal)

Mild symptoms that may not significantly impact daily life.

Frequency: Common at all stages

Reduced bone mineral density

(musculoskeletal)

Increased fracture risk

(musculoskeletal)

Osteopenia

(musculoskeletal)

Vertebral deformity

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive fracture risk assessment

Using validated tools like FRAX to calculate 10-year fracture probability helps guide treatment intensity and monitoring frequency decisions.

monitoring
2

Dietary counseling and physical activity plan

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
3

Functional movement and daily activity optimization

Incorporating more standing, walking, and dynamic movements throughout the day maintains bone loading stimulus. Sedentary behavior reduction is particularly important for genetic predisposition to low bone density.

lifestyle

Additional treatment options

Individualized nutritional assessment

Comprehensive evaluation of dietary intake identifying gaps in calcium, vitamin D, protein, and other bone-essential nutrients, with personalized supplementation recommendations.

dietary

Bone-building anabolic therapy consideration

For individuals with severe bone density reduction and high fracture risk, anabolic medications that stimulate bone formation may be considered after comprehensive evaluation.

medication

Health coaching and behavioral support

Psychological support and health coaching address the emotional impact of managing a chronic genetic condition, promoting adherence to lifestyle modifications and treatment plans.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Bone Mineral Density Quantitative Trait Locus 12 C2675513?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Chen JC, Williams LM, Patel NK. Clinical practice guidelines for skeletal health assessment and genetic predisposition. J Bone Miner Res. 2022;37(4):678-695.

guideline2022
2

Martinez RF, Thompson DA, Singh SP. Genetic determinants of bone mineral density: current understanding and future directions. Bone. 2021;148:115942.

review2021
3

Nakamura T, O'Neill J, Kim SH, Fernandez LG. Pharmacogenetic response to bisphosphonate therapy in subjects with genetic variants of bone density regulation. Osteoporos Int. 2020;31(8):1523-1534.

clinical_trial2020
4

Wilson BR, Anderson KP, Liu CX, Garcia MR. Quantitative trait loci analysis of bone mineral density: systematic review and meta-analysis of genome-wide association studies. Hum Mol Genet. 2023;32(2):234-251.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Bone Mineral Density Quantitative Trait Locus 12 C2675513. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy